Search

Filters

Clear All
  • 12
  • 44
  • 538

Phase

  • 9
  • 14
  • 49
  • 8
  • 66
  • 3
  • 439
  • 519
  • 256
  • 591
  • 3

Found 594 results for IU Health Enterprise System

A listing of IU Health Enterprise System medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

 The Adjustment, Behavior, Language and Executive Functioning Project

The Adjustment, Behavior, Language and Executive Functioning Project (ABLE)

I
Irina Castellanos
3 years - 6 years
Accepts healthy volunteer
All genders
We are actively recruiting preschool children (both Cochlear Implant users and Normal Hearing) to participate in a new, NIH funded, longitudinal research study on psychosocial outcomes, titled The Adjustment, Behavior, Language and Executive Functioning (ABLE) Project. In the ABLE project, we investigate how preschool children’s ability to identify, plan, execute, …

A Prospective, Non-interventional (NIS), Long-term, Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin

J
John Fuqua, MD
All genders
Observational
What is the purpose of this study?This is a non-interventional, observational research study of a marketed drug, Skytrofa. The purpose of this study is to evaluate the long-term effectiveness and safety of Skytrofa treatment in a large group of subjects. Skytrofa is approved in the U.S. for sale and use …

A US Multi-center, Prospective, Non-interventional, Long Term, Effectiveness and Safety Study of Patients Treated With SKYTROFA (Lonapegsomatropin)

J
John Fuqua, MD
1 years - 17 years
All genders
Observational
Why is this study being done?This is a non-interventional, observational research study of a marketed drug, Skytrofa. These studies are carried out to identify and/or measure effects of medicines or treatment under real-life conditions.  Skytrofa is approved in the U.S. for sale and use in children with growth hormone deficiency …

MODERN: An Integrated Phase 2/3 and Phase 3 Trial of MRD-Based Optimization of ADjuvant ThErapy in URothelial CaNcer

T
Tareq Salous
18 years - 100 years
All genders
Phase 2/3
What is this study about?This phase II/III trial examines whether patients who have undergone surgical removal of bladder, but require an additional treatment called immunotherapy to help prevent their bladder cancer from coming back, can be identified by a blood test. Many types of tumors tend to lose cells or …
 Immune Mechanisms of Hypertension and Cardiovascular Disease

Immune Mechanisms of Hypertension and Cardiovascular Disease

M
Meena Madhur
18 years - 85 years
Accepts healthy volunteer
All genders
Why is this study being done?The Division of Clinical Pharmacology at Indiana University is looking for volunteers with and without high blood pressure to participate in a research study to better understand how the immune system regulates blood pressure and cardiovascular disease.  This study will look at the differences in …

Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder

L
Leslie Hulvershorn, MD, MSc
10 years - 17 years
All genders
Phase 3
Interventional
This study investigates the safety and tolerability of an investigational medication in young people with schizophrenia or bipolar disorder.  Schizophrenia is a mental disorder that affects how a person thinks, feels, and behaves. Bipolar disorder is a condition that causes extreme mood swings, including emotional highs (mania or hypomania) and lows (depression)

Inhibition of Small Conductance Calcium-Activated Potassium Current: A New Therapeutic Approach for Atrial Fibrillation

J
James Tisdale
18 years - 100 years
All genders
Interventional
What is the purpose of this study?Atrial fibrillation/ atrial flutter are common irregular heart beats or arrhythmias that causes quivering of the heart and sometimes a very fast heart rate and can lead to blood clots and strokes.  Many of the current drugs on the market used to treat atrial …

NearWave optical molecular monitoring for predicting complete pathological response (pCR) to neoadjuvant chemotherapy (NAC) in breast cancer patients

T
Tarah Ballinger, MD
18 years - 100 years
Female
The purpose of this study is to assess the feasibility of the NearWave optical molecular monitoring system for monitoring therapy progression and predicting pathologic complete response (pCR) of breast cancer patients undergoing neoadjuvant chemotherapy (NAC). Interested in participating? For more information about this research study or other cancer-related clinical trials at …

Standardized Microbiota Transplant Therapy in Crohn's Disease - Pilot Trial

M
Monika Fischer, MD
18 years - 100 years
All genders
Phase 2
Interventional
Crohn's disease (CD) develops because of a disruption of homeostasis between the gut microbiota and the host immune system resulting in excessive inflammation in the intestinal tract. Current drug therapies for CD are directed at the immune system. The emergence of fecal microbiota transplantation (FMT) for the treatment of recurrent …

Denosumab for Type 1 Diabetes

C
Carmella Evans-Molina, MD
18 years - 50 years
All genders
Phase 1/2
Interventional
Researchers at City of Hope (California), University of Alabama at Birmingham, and Indiana University are studying a medication called denosumab as a potential treatment for people with type 1 diabetes. Denosumab, also known as Prolia, is a drug that has been approved by the Food and Drug Administration for bone …
21 - 30 of 594